|
| |
 |
|---|
|
Update On the Use of Contrast Media in Cardiac Imaging and
Renal Safety, Kuala Lumpur – 14 Aug 2007 | |
by
Dr Evelyn Ho
|
 |
|
L to R: Dr John Lau,
Medical Affairs Director, Medical Diagnostics, GE
Healthcare; Dr Melvin Tan (Consultant Cardiologist), Dr John
Hoe (Consultant Radiologist), Prof Dr Peter Aspelin
(Professor in Medical Radiology) and Dr Evelyn Ho (President
of the College of Radiology, AMM) |
An evening symposium on the above theme was held in Le Meridien,
Kuala Lumpur. The series of lectures were delivered by invited
speakers, Dr John Hoe, Consultant Radiologist; Dr Melvin Tan,
Consultant Cardiologist both of whom were from Singapore and
Professor Dr Peter Aspelin, Professor in Medical Radiology from
Huddinge University Hospital in Sweden. The sponsor was
GE
Healthcare Medical Diagnostics.
Contrast-induced nephropathy (CIN) is a serious complication of
contrast-enhanced imaging procedures. CIN means damage to the
kidneys by contrast media, tending to occur if a person already has
existent kidney (renal) impairment and more so if the person has
diabetes as well. It is the third most common cause of
hospital-acquired kidney failure and in high risk patients; the
incidence of CIN can be as high as 50%. Professor Dr Peter Aspelin
spoke on “How to prevent contrast induced nephropathy”, discussing
clinical trials, consequences of CIN, identifying those at risk of
CIN, and offered practical strategies to prevent this serious
disorder. In his presentation, he told the audience, especially the
radiologists they needed to know how to calculate/gauge renal
function better before using contrast media in their procedures.
Radiologists also needed to “re-learn” renal physiology to enable
them to manage their patients better. Knowing the variety of
contrast media was important, including those which were more “renal
friendly” – one of which in his studies proved to be
Visipaque.
Prof Aspelin spoke after Dr John Hoe’s lecture on “Non invasive
imaging of coronary plaque with Multi-Slice Computed Tomography (MSCT)
and clinical implications”. Dr Hoe expounded on coronary plaque
characterisation, risk stratification and the role of MSCT including
its limitations in the management of a patient with suspected or
existing coronary artery disease.
Following on Dr Hoe’s lecture was Dr Melvin Tan’s exposition on
“What an interventional cardiologist needs to know about the use of
iodinated contrast media”. Besides discussing contrast media used in
interventional cardiology or radiology, he expanded on the use of
MSCT, including the radiation protection issues.
It was therefore a rather interesting series of lectures, displaying
the crossing of boundaries in skill and expertise as well as
knowledge – a good reflection of the evolving practice of medicine!
Imagine the radiologists speaking of coronary artery risk
stratification and classification of coronary plaques or renal
physiology and CIN while the cardiologist spoke about contrast media
and radiation protection - the latter being traditionally a field
where only radiologists were conversant with.
Similarly the audience was a motley group made up of the
radiological community and their physician colleagues from
cardiology, nephrology, urology, and some from other disciplines and
the paramedical staff who form part of the radiological or
interventional practitioner’s team.
|
|---|
|
|
>>>
Click Here to return to news headlines |
|
|
Copyright © 2001-2008 College of Radiology, Academy of Medicine of Malaysia All Rights Reserved
Terms of Use Last Updated:
Monday, 21 January 2008 |
|